Sökning: onr:"swepub:oai:lup.lub.lu.se:5b09509b-f772-40f2-bb8e-a334183bbda3" >
Risk of subsequent ...
Risk of subsequent primary lymphoma in a cohort of 69,460 five-year survivors of childhood and adolescent cancer in Europe : The PanCareSurFup study
-
- Dudley, Isabelle M. (författare)
- University of Birmingham
-
- Sunguc, Ceren (författare)
- University of Birmingham
-
- Heymer, Emma J. (författare)
- University of Birmingham
-
visa fler...
-
- Winter, David L. (författare)
- University of Birmingham
-
- Teepen, Jop C. (författare)
- Princess Maxima Center for Pediatric Oncology/Hematology
-
Belle, Fabiën N. (författare)
-
- Bárdi, Edit (författare)
- St. Anna Children's Hospital,Kepler University Hospital Linz
-
- Bagnasco, Francesca (författare)
- Gaslini Children's Hospital
-
- Gudmundsdottir, Thorgerdur (författare)
- National University Hospital of Iceland,Danish Cancer Society
-
- Skinner, Roderick (författare)
- Newcastle upon Tyne Hospitals NHS Trust,University of Newcastle upon Tyne
-
- Michel, Gisela (författare)
- University of Lucerne
-
- Byrne, Julianne (författare)
- Boyne Research Institute
-
- Øfstaas, Hilde (författare)
- Norwegian Radium Hospital
-
- Jankovic, Momcilo (författare)
- University of Milano-Bicocca
-
- Mazić, Maja Česen (författare)
- University Children's Hospital, Ljubljana
-
Mader, Luzius (författare)
-
- Loonen, Jaqueline (författare)
- Radboud University Medical Center
-
- Garwicz, Stanislaw (författare)
- Lund University,Lunds universitet,Pediatrik, Lund,Sektion V,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Sena effekter efter barncancerbehandling,Forskargrupper vid Lunds universitet,Paediatrics (Lund),Section V,Department of Clinical Sciences, Lund,Faculty of Medicine,Late effects after childhood cancer treatment,Lund University Research Groups,Skåne University Hospital
-
- Wiebe, Thomas (författare)
- Lund University,Lunds universitet,Pediatrik, Lund,Sektion V,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Sena effekter efter barncancerbehandling,Forskargrupper vid Lunds universitet,Paediatrics (Lund),Section V,Department of Clinical Sciences, Lund,Faculty of Medicine,Late effects after childhood cancer treatment,Lund University Research Groups,Skåne University Hospital
-
- Alessi, Daniela (författare)
- Citta' della Salute e della Scienza Hospital-University of Turin,University of Turin
-
- Allodji, Rodrigue S. (författare)
- Centre for Research in Epidemiology and Population Health (CESP)
-
- Haddy, Nadia (författare)
- Centre for Research in Epidemiology and Population Health (CESP)
-
- Grabow, Desiree (författare)
- Johannes-Gutenberg University Mainz
-
- Kaatsch, Peter (författare)
- Johannes-Gutenberg University Mainz
-
- Kaiser, Melanie (författare)
- Johannes-Gutenberg University Mainz
-
- Maule, Milena M. (författare)
- Citta' della Salute e della Scienza Hospital-University of Turin,University of Turin
-
- Jakab, Zsuzsanna (författare)
- Semmelweis University
-
- Gunnes, Maria Winther (författare)
- Norwegian Radium Hospital,Cancer Registry of Norway, Institute of Population-Based Cancer Research
-
- Terenziani, Monica (författare)
- Istituto Nazionale dei Tumori
-
- Zaletel, Lorna Zadravec (författare)
- Institute of Oncology, Ljubljana
-
- Kuehni, Claudia E. (författare)
- University Children's Hospital Bern
-
- Haupt, Riccardo (författare)
- Gaslini Children's Hospital
-
- de Vathaire, Florent (författare)
- Centre for Research in Epidemiology and Population Health (CESP)
-
- Kremer, Leontien C. (författare)
- Princess Maxima Center for Pediatric Oncology/Hematology,Academic Medical Center of University of Amsterdam (AMC)
-
- Lähteenmäki, Päivi M. (författare)
- Turku University Hospital
-
- Winther, Jeanette F. (författare)
- Aarhus University Hospital,Danish Cancer Society
-
- Hjorth, Lars (författare)
- Lund University,Lunds universitet,Pediatrik, Lund,Sektion V,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Sena effekter efter barncancerbehandling,Forskargrupper vid Lunds universitet,LUCC: Lunds universitets cancercentrum,Övriga starka forskningsmiljöer,Paediatrics (Lund),Section V,Department of Clinical Sciences, Lund,Faculty of Medicine,Late effects after childhood cancer treatment,Lund University Research Groups,LUCC: Lund University Cancer Centre,Other Strong Research Environments,Skåne University Hospital
-
- Hawkins, Michael M. (författare)
- University of Birmingham
-
- Reulen, Raoul C. (författare)
- University of Birmingham
-
visa färre...
-
(creator_code:org_t)
- 2022-11-29
- 2023
- Engelska 15 s.
-
Ingår i: Cancer. - : Wiley. - 0008-543X .- 1097-0142. ; 129:3, s. 426-440
- Relaterad länk:
-
http://dx.doi.org/10... (free)
-
visa fler...
-
https://lup.lub.lu.s...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- Background: Survivors of Hodgkin lymphoma (HL) are at risk of developing non-Hodgkin lymphoma (NHL) after treatment; however, the risks of developing subsequent primary lymphomas (SPLs), including HL and NHL, after different types of childhood cancer are unknown. The authors quantified the risk of SPLs using the largest cohort of childhood cancer survivors worldwide. Methods: The Pan-European Network for Care of Survivors After Childhood and Adolescent Cancer (PanCare) Survivor Care and Follow-Up Studies (PanCareSurFup) cohort includes 69,460 five-year survivors of childhood cancer, diagnosed during 1940 through 2008, from 12 European countries. Risks of SPLs were quantified by standardized incidence ratios (SIRs) and relative risks (RRs) using multivariable Poisson regression. Results: Overall, 140 SPLs, including 104 NHLs and 36 HLs, were identified. Survivors were at 60% increased risk of an SPL compared with the general population (SIR, 1.6; 95% confidence interval [CI], 1.4–1.9). Survivors were twice as likely to develop NHL (SIR, 2.3; 95% CI, 1.9–2.8), with the greatest risks among survivors of HL (SIR, 7.1; 95% CI, 5.1–10.0), Wilms tumor (SIR, 3.1; 95% CI, 1.7–5.7), leukemia (SIR, 2.8; 95% CI, 1.8–4.4), and bone sarcoma (SIR, 2.7; 95% CI, 1.4–5.4). Treatment with chemotherapy for any cancer doubled the RR of NHL (RR, 2.1; 95% CI, 1.2–3.9), but treatment with radiotherapy did not (RR, 1.2; 95% CI, 0.7–2.0). Survivors were at similar risk of developing a subsequent HL as the general population (SIR, 1.1; 95% CI, 0.8–1.5). Conclusions: In addition to HL, the authors show here for the first time that survivors of Wilms tumor, leukemia, and bone sarcoma are at risk of NHL. Survivors and health care professionals should be aware of the risk of NHL in these survivors and in any survivors treated with chemotherapy.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
Nyckelord
- childhood cancer survivors
- Hodgkin lymphoma
- late effects
- non-Hodgkin lymphoma
- second cancers
- subsequent primary lymphoma
Publikations- och innehållstyp
- art (ämneskategori)
- ref (ämneskategori)
Hitta via bibliotek
-
Cancer
(Sök värdpublikationen i LIBRIS)
Till lärosätets databas
- Av författaren/redakt...
-
Dudley, Isabelle ...
-
Sunguc, Ceren
-
Heymer, Emma J.
-
Winter, David L.
-
Teepen, Jop C.
-
Belle, Fabiën N.
-
visa fler...
-
Bárdi, Edit
-
Bagnasco, France ...
-
Gudmundsdottir, ...
-
Skinner, Roderic ...
-
Michel, Gisela
-
Byrne, Julianne
-
Øfstaas, Hilde
-
Jankovic, Momcil ...
-
Mazić, Maja Čese ...
-
Mader, Luzius
-
Loonen, Jaquelin ...
-
Garwicz, Stanisl ...
-
Wiebe, Thomas
-
Alessi, Daniela
-
Allodji, Rodrigu ...
-
Haddy, Nadia
-
Grabow, Desiree
-
Kaatsch, Peter
-
Kaiser, Melanie
-
Maule, Milena M.
-
Jakab, Zsuzsanna
-
Gunnes, Maria Wi ...
-
Terenziani, Moni ...
-
Zaletel, Lorna Z ...
-
Kuehni, Claudia ...
-
Haupt, Riccardo
-
de Vathaire, Flo ...
-
Kremer, Leontien ...
-
Lähteenmäki, Päi ...
-
Winther, Jeanett ...
-
Hjorth, Lars
-
Hawkins, Michael ...
-
Reulen, Raoul C.
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Cancer och onkol ...
- Artiklar i publikationen
-
Cancer
- Av lärosätet
-
Lunds universitet